Cargando…

Cell-based therapies for rheumatoid arthritis: opportunities and challenges

Rheumatoid arthritis (RA) is the most common immune-mediated inflammatory disease characterized by chronic synovitis that hardly resolves spontaneously. The current treatment of RA consists of nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, conventional disease-modifying antirheumati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yu-Jing, Chen, Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131381/ https://www.ncbi.nlm.nih.gov/pubmed/35634355 http://dx.doi.org/10.1177/1759720X221100294

Ejemplares similares

Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges
por: Lv, Xiaolan, et al.
Publicado: (2021)

Challenges and Opportunities of Targeted Behavioral Interventions for Groups at Risk for Developing Rheumatoid Arthritis
por: Zaccardelli, Alessandra, et al.
Publicado: (2021)

Calcium-Permeable Channels Cooperation for Rheumatoid Arthritis: Therapeutic Opportunities
por: Liang, Hong-Yu, et al.
Publicado: (2022)

Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America
por: Pineda, Carlos, et al.
Publicado: (2015)

Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice
por: Siddle, Heidi J, et al.
Publicado: (2023)

Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal/Stem Cell-Based Therapies
por: Shimizu, Yusuke, et al.
Publicado: (2023)

Emerging Concepts and Challenges in Rheumatoid Arthritis Gene Therapy
por: Deviatkin, Andrei A., et al.
Publicado: (2020)

Cell‐based therapies for the treatment of rheumatoid arthritis
por: Moghaddam, Maryam Zare, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
por: Sarsenova, Madina, et al.
Publicado: (2021)

Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis
por: Roszkowski, Leszek, et al.
Publicado: (2021)

Microbiome–miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities
por: Lu, Haifeng, et al.
Publicado: (2021)

Rheumatoid arthritis in patients with HIV: management challenges
por: Carroll, Matthew B, et al.
Publicado: (2016)

Challenges and opportunities of publishing supplements at Arthritis Research & Therapy
por: Mulvany, Frances, et al.
Publicado: (2010)

Stem cells in cancer therapy: opportunities and challenges
por: Zhang, Cheng-Liang, et al.
Publicado: (2017)

Management of rheumatoid arthritis during pregnancy: challenges and solutions
por: Krause, Megan L, et al.
Publicado: (2016)

The impact of fatigue in rheumatoid arthritis and the challenges of its assessment
por: Santos, Eduardo J F, et al.
Publicado: (2019)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
por: Paroli, Marino, et al.
Publicado: (2023)

Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities
por: Zhao, Ting, et al.
Publicado: (2022)

T cells in rheumatoid arthritis
por: Cope, Andrew P
Publicado: (2008)

Signaling pathways in rheumatoid arthritis: implications for targeted therapy
por: Ding, Qian, et al.
Publicado: (2023)

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
por: Yang, Han, et al.
Publicado: (2023)

H(2)S-based therapies for ischaemic stroke: opportunities and challenges
por: Jia, Jia, et al.
Publicado: (2019)

Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis
por: Chen, Shyi-Jou, et al.
Publicado: (2019)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Tuscano, Joseph M, et al.
Publicado: (2009)

Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis
por: Thomas, Ranjeny
Publicado: (2013)

Genetically modified T cells in cancer therapy: opportunities and challenges
por: Sharpe, Michaela, et al.
Publicado: (2015)

Proton Therapy for Prostate Cancer: Challenges and Opportunities
por: Poon, Darren M. C., et al.
Publicado: (2022)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis
por: Williams, Richard O.
Publicado: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
por: Feely, Michael G
Publicado: (2010)

Photosensitizers Used in the Photodynamic Therapy of Rheumatoid Arthritis
por: Gallardo-Villagrán, Manuel, et al.
Publicado: (2019)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen, Kate E, et al.
Publicado: (2021)

Role of miRNAs in Rheumatoid Arthritis Therapy
por: Zhang, Yiping, et al.
Publicado: (2023)

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
por: Liu, Qiaolin, et al.
Publicado: (2023)

Stem cell therapy for osteonecrosis of femoral head: Opportunities and challenges
por: Xu, Yingxing, et al.
Publicado: (2020)

Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy
por: Xie, Yingsi, et al.
Publicado: (2020)

Regulatory T cells in rheumatoid arthritis
por: Leipe, Jan, et al.
Publicado: (2005)

B cells in rheumatoid arthritis
por: Kim, Hye-Jung, et al.
Publicado: (2000)

Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
por: Karsdal, Morten A, et al.
Publicado: (2011)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iqk37r93r23hrv3p83o5r23gg5